Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemothe
暂无分享,去创建一个
Y. Ohe | Takuhiro Yamaguchi | Y. Uchitomi | H. Hashimoto | S. Iwasa | N. Yamamoto | S. Zenda | M. Abe | T. Yanai | H. Fukuda | M. Mori